Clinical Trial Update: Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low molecular weight heparin prophylaxis for placental-mediated complications of pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placental Insufficiency
• Preeclampsia

Drugs mentioned

• Low molecular weight heparin prophylaxis (low molecular weight heparin)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: High Risk Pregnant Women, Placental Insufficiency | Phase 3 | Status: COMPLETED